PEG products with additional MW may be made to order, please contact us for details
Amine PEG8 Amine
$384.00 – $1,280.00
Monodisperse Amine PEG8 Amine reagent with superior quality specification of ≥ 95% Purity.
Monodisperse Amine PEG Amine from JenKem Technology (discrete single molecule PEG diamine) is a homobifunctional PEG employed for PEGylation via stable linkages, such as amide, urethane, urea, or secondary amine. Monodisperse homobifunctional PEG derivatives from JenKem Technology are high quality crosslinkers for PEGylation of proteins and peptides, nanoparticle and surface modifications. Conjugation with homobifunctional PEGs provides an increased drug load compared to PEGylation using linear PEGs. JenKem Technology’s monodisperse discrete PEG diAmine products are produced via very reproducible chemical reactions and lack the polydispersity of traditional PEG polymers. JenKem’s monodisperse diamine PEGs retain the polyethylene glycol’s good solubility in water, while offering to PEGylated drugs the same PEG benefits of reduced aggregation and immunogenicity, and increased hydrodynamic volume.
JenKem Technology offers monodisperse Amine PEG Amine with MW 368.5 Da (NH2-PEG8-NH2) and MW 544.8 Da (NH2-PEG12-NH2), in 1g and 5g packing sizes. diAmine PEGs with different numbers of -CH2-CH2-O- units, such as Amine PEG4 Amine (NH2-PEG4-NH2), may be available by custom synthesis, please email us at firstname.lastname@example.org for details on custom PEGs. JenKem Technology provides repackaging services for an additional fee, please contact us if you require a different package size than our catalog selection.
Bulk PEGs and GMP grade PEGs are made-to-order. Please contact us for bulk pricing.
1. El-Gogary, R.I., et al., Polyethylene Glycol Conjugated Polymeric Nanocapsules for Targeted Delivery of Quercetin to Folate-Expressing Cancer Cells in Vitro and in Vivo. ACS Nano, 2014, 8(2), p. 1384-1401.
2. Zhou, J., et al., In vivo evaluation of medical device-associated inflammation using a macrophage-specific positron emission tomography (PET) imaging probe. Bioorganic & Medicinal Chemistry Letters, 2013, 23(7), p. 2044-2047.
3. Hutanu, D., et al., Recent Applications of Polyethylene Glycols (PEGs) and PEG Derivatives. Mod Chem appl, 2014, 2:132. doi: 10.4172/2329-6798.1000132. Read about select applications of JenKem® PEGs in the medical device, drug development, and diagnostics areas, including drug delivery, wound healing, cell culture models, and tissue regeneration.
Founded in 2001 by experts in PEG synthesis and PEGylation, JenKem Technology specializes exclusively in the development and manufacturing of high quality polyethylene glycol (PEG) products and derivatives, and related custom polymer synthesis and PEGylation services. JenKem Technology is ISO 9001 and ISO 13485 certified, and adheres to ICH Q7A guidelines for GMP manufacture. The production of JenKem® PEGs is back-integrated to in-house polymerization from ethylene oxide, enabling facile traceability for regulated customers. JenKem Technology caters to the PEGylation needs of the pharmaceutical, biotechnology, medical device and diagnostics, and emerging chemical specialty markets, from laboratory scale through large commercial scale.